A total of 120 (27.9%) tumor samples harbored mutations in glycerolipid metabolism-related genes, with two genes identified as high frequently mutated, including DGKB (15%) and DGKD (14%) (Figure 1). This evidence concerns the gene DGKD and neoplasm.